Fig. 6From: Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with gliomaROC analysis and construction and validation of the nomogram based on TPM4 expression. A nomogram for predicting the probability of 1-, 2- and 3-year OS in glioma patients (A). Calibration plots validate the efficiency of nomograms for OS (B). Time-dependent survival ROC curve analysis to predict 1-, 2- and 3-year survival rates (C)Back to article page